“That was a little bit intimidating,” recalls West, now the vice president and general manager of Illumina's DNA sequencing business unit following the acquisition of Solexa Ltd. by Illumina.

In June 2007, Stanford's David Johnson teamed up with Barbara Wold of Pasadena's California Institute of Technology, using Illumina's Solexa platform to develop a high-throughput method for ...

Illumina aims to transform human health practices through its leadership of genomic sequencing and related applications. The firm provides a broad range of instruments and related consumables to ...